News

Fierce Pharma13d
Novo's Wegovy takes a hit from compounders, but company expects faster second-half growth
As Novo Nordisk works through a period of transition in the U.S. GLP-1 drug market, sales from the company's star obesity ...
KXAN19d
Novo Nordisk announces that CVS Caremark®, the country’s
PLAINSBORO, N.J., May 1, 2025 /PRNewswire/ -- Today, Novo Nordisk announced that CVS ... preferred GLP-1 medicine on its largest commercial template formularies. This change will be effective ...